(Total Views: 581)
Posted On: 11/11/2025 6:33:11 PM
Post# of 158791
Re: Buddyboy20 #158402
cost of CAR T cell therapy
According to Wikipedia:
"The cost of CAR T cell therapies has been criticized, with the initial costs of tisagenlecleucel (Kymriah) and axicabtagene ciloleucel (Yescarta) being $375,000 and $475,000 respectively.[119] The high cost of CAR T therapies is due to complex cellular manufacturing in specialized good manufacturing practice (GMP) facilities as well as the high level of hospital care necessary after CAR T cells are administered due to risks such as cytokine release syndrome.[119] In the United States, CAR T cell therapies are covered by Medicare and by many but not all private insurers.[135][136] Manufacturers of CAR T cells have developed alternative payment programs due to the high cost of CAR T therapy, such as by requiring payment only if the CAR T therapy induces a complete remission by a certain time point after treatment.[137]
Additionally, CAR T cell therapies are not available worldwide yet. CAR T cell therapies have been approved in China, Australia, Singapore, the United Kingdom, and some European countries.[138] In February 2022 Brazil approved tisagenlecleucel (Kymriah) treatment.[139]"
That's pretty expensive.
According to Wikipedia:
"The cost of CAR T cell therapies has been criticized, with the initial costs of tisagenlecleucel (Kymriah) and axicabtagene ciloleucel (Yescarta) being $375,000 and $475,000 respectively.[119] The high cost of CAR T therapies is due to complex cellular manufacturing in specialized good manufacturing practice (GMP) facilities as well as the high level of hospital care necessary after CAR T cells are administered due to risks such as cytokine release syndrome.[119] In the United States, CAR T cell therapies are covered by Medicare and by many but not all private insurers.[135][136] Manufacturers of CAR T cells have developed alternative payment programs due to the high cost of CAR T therapy, such as by requiring payment only if the CAR T therapy induces a complete remission by a certain time point after treatment.[137]
Additionally, CAR T cell therapies are not available worldwide yet. CAR T cell therapies have been approved in China, Australia, Singapore, the United Kingdom, and some European countries.[138] In February 2022 Brazil approved tisagenlecleucel (Kymriah) treatment.[139]"
That's pretty expensive.
(5)
(0)
